Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B

Strain 1470 is the standard typing strain for serogroup F of Clostridium difficile containing both toxin genes, toxA‐1470 and toxB‐1470. A polymerase chain reaction (PCR)‐based approach to the sequencing of the total toxB‐1470 gene identified an open reading frame (ORF) of 7104 nucleotides. In comparison with the previously sequenced toxB of C. difficile VPI10463, the toxB‐1470 gene has 16 additional nucleotides, 13 within the 5′‐untranslated region and three within the coding region. The Mr of ToxB‐1470 is 269 262, with an isoelectric point (IP) of 4.16. The equivalent values for ToxB are Mr 269 709 and IP 4.13. In comparison with ToxB, ToxB‐1470 differs primarily in the N‐terminal region between positions 1 and 868 where 148 amino acids residues are changed. The C‐terminal region between residues 869–2367 is highly conserved with only six amino acid alterations. Dot matrix comparison of ToxB‐1470 with ToxA and ToxB reveals the highest homology between ToxB‐1470 and ToxB. Thus ToxB‐1470 did not originate from recombination between ToxA and ToxB. On cultured endothelial cells, from porcine pulmonary artery, purified ToxB‐1470 is less potent than ToxB. The cytopathic effects of ToxB‐1470 are indistinguishable from those caused by the lethal toxin (LT) of Clostridium sordellii, but are clearly different from the patterns observed after exposure of endothelial cells to ToxA and ToxB of C. difficile (VPI10463) or α‐toxin (Tcnα) of Clostridium novyi. The LT‐like action of ToxB‐1470 was not due to altered internalization processes, as microinjection and addition to the medium induced identical effects on the cells. Since the differences between ToxB and ToxB‐1470 are clustered within the N‐terminal third of the respective proteins, we conclude that these domains carry the toxic determinants. A three‐domain structure is proposed for the family of large clostridal cytotoxins.

[1]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[2]  K. Aktories,et al.  Clostridium difficile toxin B acts on the GTP-binding protein Rho. , 1994, The Journal of biological chemistry.

[3]  G. Schiavo,et al.  Tetanus and botulism neurotoxins: a new group of zinc proteases. , 1993, Trends in biochemical sciences.

[4]  C. Eichel-Streiber Molecular Biology of the Clostridium difficile Toxins , 1993 .

[5]  Arndt Rolfs,et al.  PCR: Clinical Diagnostics and Research , 1992 .

[6]  A. Price,et al.  Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.

[7]  Anne J. Ridley,et al.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.

[8]  J. Mekalanos,et al.  Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Eisenberg,et al.  pH-dependent insertion of proteins into membranes: B-chain mutation of diphtheria toxin that inhibits membrane translocation, Glu-349----Lys. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. von Eichel-Streiber,et al.  Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton , 1992, Infection and immunity.

[11]  T. Wilkins,et al.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A , 1992, Infection and immunity.

[12]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[13]  I. Pastan,et al.  Translocation mediated by domain II of Pseudomonas exotoxin A: transport of barnase into the cytosol. , 1992, Biochemistry.

[14]  J. Verhoef,et al.  Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B , 1991, Journal of clinical microbiology.

[15]  V. Wilson,et al.  Classification of medically important clostridia using restriction endonuclease site differences of PCR-amplified 16S rDNA. , 1991, Journal of general microbiology.

[16]  J. Torres Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. , 1991, Journal of medical microbiology.

[17]  C. von Eichel-Streiber,et al.  A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. , 1991, Toxicon : official journal of the International Society on Toxinology.

[18]  R. Zollinger,et al.  Role of surgery in antibiotic-induced pseudomembranous enterocolitis. , 1990, American journal of surgery.

[19]  L. A. Barroso,et al.  Nucleotide sequence of Clostridium difficile toxin B gene , 1990, Nucleic Acids Res..

[20]  J. Johnson,et al.  Molecular characterization of the Clostridium difficile toxin A gene , 1990, Infection and immunity.

[21]  H. Sambrook Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[22]  D. Suckau,et al.  Cloning and characterization of overlapping DNA fragments of the toxin A gene of clostridium difficile. , 1989, Journal of general microbiology.

[23]  T. Wilkins,et al.  Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin) , 1988, Infection and immunity.

[24]  T. Wilkins,et al.  Clostridium difficile: its disease and toxins , 1988, Clinical Microbiology Reviews.

[25]  A. Onderdonk Chapter 7 – Role of the Hamster Model of Antibiotic-Associated Colitis in Defining the Etiology of the Disease , 1988 .

[26]  W. L. George,et al.  Chapter 3 – Antimicrobial Agent–Associated Diarrhea in Adult Humans , 1988 .

[27]  R. Collier,et al.  Expression of a mutant, full-length form of diphtheria toxin in Escherichia coli , 1987, Infection and immunity.

[28]  C. Richardson,et al.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. von Eichel-Streiber,et al.  Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. , 1987, Microbial pathogenesis.

[30]  I. Florin,et al.  Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. , 1986, Microbial pathogenesis.

[31]  D. Mckay,et al.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Seeger,et al.  Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: Membrane attack and calcium influx , 1985, Journal of cellular physiology.